Michael Houghton
British virologist (born 1949) / From Wikipedia, the free encyclopedia
Dear Wikiwand AI, let's keep it short by simply answering these key questions:
Can you list the top facts and stats about Michael Houghton (virologist)?
Summarize this article for a 10 year old
Sir Michael Houghton (born 1949) is a British scientist and Nobel Prize laureate. Along with Qui-Lim Choo, George Kuo and Daniel W. Bradley, he co-discovered Hepatitis C in 1989.[1] He also co-discovered the Hepatitis D genome in 1986.[2] The discovery of the Hepatitis C virus (HCV) led to the rapid development of diagnostic reagents to detect HCV in blood supplies, which has reduced the risk of acquiring HCV through blood transfusion from one in three to about one in two million.[3][4] It is estimated that antibody testing has prevented at least 40,000 new infections per year in the US alone and many more worldwide.[5]
Michael Houghton | |
---|---|
Born | 1949 (age 74ā75) |
Alma mater | University of East Anglia (BSc) King's College London (PhD) |
Known for | Hepatitis C Hepatitis D |
Awards | Karl Landsteiner Memorial Award (1992) Robert Koch Prize (1993) William Beaumont Prize (1994) Lasker Award (2000) Gairdner Foundation International Award (2013 ā declined) Nobel Prize for Medicine (2020) |
Scientific career | |
Fields | Microbiology Virology |
Institutions | University of Alberta Chiron Corporation |
Thesis | RNA Polymerases and Transcription in the Chicken Oviduct (1977) |
Doctoral advisor | James Chesterton |
Website | apps |
Houghton is currently Canada Excellence Research Chair in Virology and Li Ka Shing Professor of Virology at the University of Alberta, where he is also director of the Li Ka Shing Applied Virology Institute.[6] He was the co-recipient of the 2020 Nobel Prize in Physiology or Medicine along with Harvey J. Alter and Charles M. Rice.[7][8]